FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:KCNH7-SLC38A11

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: KCNH7-SLC38A11
FusionPDB ID: 41406
FusionGDB2.0 ID: 41406
HgeneTgene
Gene symbol

KCNH7

SLC38A11

Gene ID

90134

151258

Gene namepotassium voltage-gated channel subfamily H member 7solute carrier family 38 member 11
SynonymsERG3|HERG3|Kv11.3AVT2
Cytomap

2q24.2

2q24.3

Type of geneprotein-codingprotein-coding
Descriptionpotassium voltage-gated channel subfamily H member 7ERG-3eag-related protein 3ether-a-go-go-related gene potassium channel 3ether-a-go-go-related protein 3potassium channel subunit HERG-3potassium channel, voltage gated eag related subfamily H, membputative sodium-coupled neutral amino acid transporter 11
Modification date2020031320200313
UniProtAcc

Q9NS40

Main function of 5'-partner protein: FUNCTION: Pore-forming (alpha) subunit of voltage-gated potassium channel. Channel properties may be modulated by cAMP and subunit assembly.
.
Ensembl transtripts involved in fusion geneENST idsENST00000328032, ENST00000332142, 
ENST00000477019, 
ENST00000493887, 
ENST00000303735, ENST00000409058, 
ENST00000409149, ENST00000409662, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score1 X 2 X 1=26 X 5 X 7=210
# samples 211
** MAII scorelog2(2/2*10)=3.32192809488736log2(11/210*10)=-0.932885804141463
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: KCNH7 [Title/Abstract] AND SLC38A11 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: KCNH7 [Title/Abstract] AND SLC38A11 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)KCNH7(163693047)-SLC38A11(165796066), # samples:2
Anticipated loss of major functional domain due to fusion event.KCNH7-SLC38A11 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
KCNH7-SLC38A11 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
KCNH7-SLC38A11 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
KCNH7-SLC38A11 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr2:163693047/chr2:165796066)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across KCNH7 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across SLC38A11 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000332142KCNH7chr2163693047-ENST00000303735SLC38A11chr2165796066-36174071001365421
ENST00000332142KCNH7chr2163693047-ENST00000409149SLC38A11chr2165796066-14744071001365421
ENST00000332142KCNH7chr2163693047-ENST00000409058SLC38A11chr2165796066-14694071001365421
ENST00000332142KCNH7chr2163693047-ENST00000409662SLC38A11chr2165796066-14294071001365421
ENST00000328032KCNH7chr2163693047-ENST00000303735SLC38A11chr2165796066-37295192121477421
ENST00000328032KCNH7chr2163693047-ENST00000409149SLC38A11chr2165796066-15865192121477421
ENST00000328032KCNH7chr2163693047-ENST00000409058SLC38A11chr2165796066-15815192121477421
ENST00000328032KCNH7chr2163693047-ENST00000409662SLC38A11chr2165796066-15415192121477421
ENST00000332142KCNH7chr2163693046-ENST00000303735SLC38A11chr2165796066-36174071001365421
ENST00000332142KCNH7chr2163693046-ENST00000409149SLC38A11chr2165796066-14744071001365421
ENST00000332142KCNH7chr2163693046-ENST00000409058SLC38A11chr2165796066-14694071001365421
ENST00000332142KCNH7chr2163693046-ENST00000409662SLC38A11chr2165796066-14294071001365421
ENST00000328032KCNH7chr2163693046-ENST00000303735SLC38A11chr2165796066-37295192121477421
ENST00000328032KCNH7chr2163693046-ENST00000409149SLC38A11chr2165796066-15865192121477421
ENST00000328032KCNH7chr2163693046-ENST00000409058SLC38A11chr2165796066-15815192121477421
ENST00000328032KCNH7chr2163693046-ENST00000409662SLC38A11chr2165796066-15415192121477421

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000332142ENST00000303735KCNH7chr2163693047-SLC38A11chr2165796066-0.0005141650.99948585
ENST00000332142ENST00000409149KCNH7chr2163693047-SLC38A11chr2165796066-0.000639610.9993604
ENST00000332142ENST00000409058KCNH7chr2163693047-SLC38A11chr2165796066-0.0006338690.9993661
ENST00000332142ENST00000409662KCNH7chr2163693047-SLC38A11chr2165796066-0.0006664870.99933344
ENST00000328032ENST00000303735KCNH7chr2163693047-SLC38A11chr2165796066-0.0005270.99947304
ENST00000328032ENST00000409149KCNH7chr2163693047-SLC38A11chr2165796066-0.0006416170.99935836
ENST00000328032ENST00000409058KCNH7chr2163693047-SLC38A11chr2165796066-0.0006380580.99936193
ENST00000328032ENST00000409662KCNH7chr2163693047-SLC38A11chr2165796066-0.0007130470.99928695
ENST00000332142ENST00000303735KCNH7chr2163693046-SLC38A11chr2165796066-0.0005141650.99948585
ENST00000332142ENST00000409149KCNH7chr2163693046-SLC38A11chr2165796066-0.000639610.9993604
ENST00000332142ENST00000409058KCNH7chr2163693046-SLC38A11chr2165796066-0.0006338690.9993661
ENST00000332142ENST00000409662KCNH7chr2163693046-SLC38A11chr2165796066-0.0006664870.99933344
ENST00000328032ENST00000303735KCNH7chr2163693046-SLC38A11chr2165796066-0.0005270.99947304
ENST00000328032ENST00000409149KCNH7chr2163693046-SLC38A11chr2165796066-0.0006416170.99935836
ENST00000328032ENST00000409058KCNH7chr2163693046-SLC38A11chr2165796066-0.0006380580.99936193
ENST00000328032ENST00000409662KCNH7chr2163693046-SLC38A11chr2165796066-0.0007130470.99928695

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for KCNH7-SLC38A11

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
KCNH7chr2163693046SLC38A11chr2165796066407102EERKVEVTYYHKNVDPENVFIGRHFI
KCNH7chr2163693046SLC38A11chr2165796066519102EERKVEVTYYHKNVDPENVFIGRHFI
KCNH7chr2163693047SLC38A11chr2165796066407102EERKVEVTYYHKNVDPENVFIGRHFI
KCNH7chr2163693047SLC38A11chr2165796066519102EERKVEVTYYHKNVDPENVFIGRHFI

Top

Potential FusionNeoAntigen Information of KCNH7-SLC38A11 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
KCNH7-SLC38A11_163693046_165796066.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-B15:03HKNVDPENVF0.97630.62291020
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-B15:18HKNVDPENVF0.9750.59871020
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-B39:01YHKNVDPENVF0.99920.8469920
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-B38:01YHKNVDPENVF0.99840.887920
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-B15:18YHKNVDPENVF0.99810.5731920
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-B38:02YHKNVDPENVF0.99780.9035920
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-C04:10NVDPENVF10.52841220
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-C04:07NVDPENVF10.51271220
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-C05:09NVDPENVF10.79321220
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-C08:15NVDPENVF0.99990.83211220
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-C05:09NVDPENVFI0.99980.78211221
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-C08:15NVDPENVFI0.99840.81271221
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-C04:06NVDPENVFI0.95530.59531221
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-C08:04NVDPENVFI0.84390.88481221
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-C08:13NVDPENVFI0.84390.88481221
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-C08:03NVDPENVFI0.54270.90941221
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-C05:09KNVDPENVFI0.99970.83281121
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-B39:12YHKNVDPENVF0.99910.8588920
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-B39:05YHKNVDPENVF0.99760.8248920
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-C18:01NVDPENVF10.55391220
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-C05:01NVDPENVF10.79321220
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-C04:01NVDPENVF10.51271220
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-C04:03NVDPENVF10.56051220
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-C08:02NVDPENVF0.99990.83211220
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-C04:03NVDPENVFI0.99980.51891221
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-C05:01NVDPENVFI0.99980.78211221
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-C18:01NVDPENVFI0.99960.51571221
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-C08:02NVDPENVFI0.99840.81271221
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-A68:02EVTYYHKNV0.98550.6615514
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-C04:04NVDPENVFI0.90050.50631221
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-C03:06NVDPENVFI0.78240.97951221
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-B48:02KNVDPENVF0.66210.84231120
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-C17:01NVDPENVFI0.60810.57441221
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-C08:01NVDPENVFI0.54270.90941221
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-C07:04NVDPENVFI0.23030.71621221
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-B07:13NVDPENVFI0.02030.65781221
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-C05:01KNVDPENVFI0.99970.83281121
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-B15:54HKNVDPENVF0.98450.74941020
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-B48:02HKNVDPENVF0.93820.85281020
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-B39:31YHKNVDPENVF0.99940.8479920
KCNH7-SLC38A11chr2163693046chr2165796066519HLA-B38:05YHKNVDPENVF0.99840.887920

Top

Potential FusionNeoAntigen Information of KCNH7-SLC38A11 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
KCNH7-SLC38A11_163693046_165796066.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0803KVEVTYYHKNVDPEN318
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0803VEVTYYHKNVDPENV419
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0806KVEVTYYHKNVDPEN318
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0806RKVEVTYYHKNVDPE217
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0810KVEVTYYHKNVDPEN318
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0810RKVEVTYYHKNVDPE217
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0810ERKVEVTYYHKNVDP116
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0810VEVTYYHKNVDPENV419
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0812KVEVTYYHKNVDPEN318
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0812RKVEVTYYHKNVDPE217
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0812ERKVEVTYYHKNVDP116
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0812VEVTYYHKNVDPENV419
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0814KVEVTYYHKNVDPEN318
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0814VEVTYYHKNVDPENV419
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0818KVEVTYYHKNVDPEN318
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0822KVEVTYYHKNVDPEN318
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0822RKVEVTYYHKNVDPE217
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0823KVEVTYYHKNVDPEN318
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0823VEVTYYHKNVDPENV419
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0827KVEVTYYHKNVDPEN318
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0827VEVTYYHKNVDPENV419
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0833KVEVTYYHKNVDPEN318
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0833VEVTYYHKNVDPENV419
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0835KVEVTYYHKNVDPEN318
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0835VEVTYYHKNVDPENV419
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0836KVEVTYYHKNVDPEN318
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0836VEVTYYHKNVDPENV419
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0837KVEVTYYHKNVDPEN318
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0837RKVEVTYYHKNVDPE217
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0837VEVTYYHKNVDPENV419
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0837ERKVEVTYYHKNVDP116
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0838KVEVTYYHKNVDPEN318
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-0838VEVTYYHKNVDPENV419
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1304KVEVTYYHKNVDPEN318
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1304RKVEVTYYHKNVDPE217
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1304ERKVEVTYYHKNVDP116
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1304VEVTYYHKNVDPENV419
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1309KVEVTYYHKNVDPEN318
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1313KVEVTYYHKNVDPEN318
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1332KVEVTYYHKNVDPEN318
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1332RKVEVTYYHKNVDPE217
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1332ERKVEVTYYHKNVDP116
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1332VEVTYYHKNVDPENV419
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1338KVEVTYYHKNVDPEN318
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1338RKVEVTYYHKNVDPE217
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1338VEVTYYHKNVDPENV419
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1338ERKVEVTYYHKNVDP116
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1343KVEVTYYHKNVDPEN318
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1343RKVEVTYYHKNVDPE217
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1348KVEVTYYHKNVDPEN318
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1348RKVEVTYYHKNVDPE217
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1348ERKVEVTYYHKNVDP116
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1348VEVTYYHKNVDPENV419
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1358KVEVTYYHKNVDPEN318
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1365KVEVTYYHKNVDPEN318
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1365RKVEVTYYHKNVDPE217
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1365VEVTYYHKNVDPENV419
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1365ERKVEVTYYHKNVDP116
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1375KVEVTYYHKNVDPEN318
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1375RKVEVTYYHKNVDPE217
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1375ERKVEVTYYHKNVDP116
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1375VEVTYYHKNVDPENV419
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1393KVEVTYYHKNVDPEN318
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1393RKVEVTYYHKNVDPE217
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1393ERKVEVTYYHKNVDP116
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1393VEVTYYHKNVDPENV419
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1416KVEVTYYHKNVDPEN318
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1416RKVEVTYYHKNVDPE217
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1437KVEVTYYHKNVDPEN318
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1437RKVEVTYYHKNVDPE217
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1463KVEVTYYHKNVDPEN318
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1478KVEVTYYHKNVDPEN318
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1478RKVEVTYYHKNVDPE217
KCNH7-SLC38A11chr2163693046chr2165796066519DRB1-1478ERKVEVTYYHKNVDP116
KCNH7-SLC38A11chr2163693046chr2165796066519DRB3-0202VTYYHKNVDPENVFI621
KCNH7-SLC38A11chr2163693046chr2165796066519DRB3-0202EVTYYHKNVDPENVF520
KCNH7-SLC38A11chr2163693046chr2165796066519DRB3-0210VTYYHKNVDPENVFI621
KCNH7-SLC38A11chr2163693046chr2165796066519DRB3-0210EVTYYHKNVDPENVF520
KCNH7-SLC38A11chr2163693046chr2165796066519DRB3-0211VTYYHKNVDPENVFI621
KCNH7-SLC38A11chr2163693046chr2165796066519DRB3-0211EVTYYHKNVDPENVF520
KCNH7-SLC38A11chr2163693046chr2165796066519DRB3-0212VTYYHKNVDPENVFI621
KCNH7-SLC38A11chr2163693046chr2165796066519DRB3-0212EVTYYHKNVDPENVF520
KCNH7-SLC38A11chr2163693046chr2165796066519DRB3-0213VTYYHKNVDPENVFI621
KCNH7-SLC38A11chr2163693046chr2165796066519DRB3-0213EVTYYHKNVDPENVF520
KCNH7-SLC38A11chr2163693046chr2165796066519DRB3-0215VTYYHKNVDPENVFI621
KCNH7-SLC38A11chr2163693046chr2165796066519DRB3-0215EVTYYHKNVDPENVF520
KCNH7-SLC38A11chr2163693046chr2165796066519DRB3-0215VEVTYYHKNVDPENV419
KCNH7-SLC38A11chr2163693046chr2165796066519DRB3-0217VTYYHKNVDPENVFI621
KCNH7-SLC38A11chr2163693046chr2165796066519DRB3-0217EVTYYHKNVDPENVF520
KCNH7-SLC38A11chr2163693046chr2165796066519DRB3-0218VTYYHKNVDPENVFI621
KCNH7-SLC38A11chr2163693046chr2165796066519DRB3-0218EVTYYHKNVDPENVF520
KCNH7-SLC38A11chr2163693046chr2165796066519DRB3-0219VTYYHKNVDPENVFI621
KCNH7-SLC38A11chr2163693046chr2165796066519DRB3-0219EVTYYHKNVDPENVF520
KCNH7-SLC38A11chr2163693046chr2165796066519DRB3-0220VTYYHKNVDPENVFI621
KCNH7-SLC38A11chr2163693046chr2165796066519DRB3-0220EVTYYHKNVDPENVF520
KCNH7-SLC38A11chr2163693046chr2165796066519DRB3-0222VTYYHKNVDPENVFI621
KCNH7-SLC38A11chr2163693046chr2165796066519DRB3-0222EVTYYHKNVDPENVF520
KCNH7-SLC38A11chr2163693046chr2165796066519DRB3-0223VTYYHKNVDPENVFI621
KCNH7-SLC38A11chr2163693046chr2165796066519DRB3-0223EVTYYHKNVDPENVF520
KCNH7-SLC38A11chr2163693046chr2165796066519DRB3-0225VTYYHKNVDPENVFI621
KCNH7-SLC38A11chr2163693046chr2165796066519DRB3-0225EVTYYHKNVDPENVF520

Top

Fusion breakpoint peptide structures of KCNH7-SLC38A11

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
10338VTYYHKNVDPENVFKCNH7SLC38A11chr2163693046chr2165796066519

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of KCNH7-SLC38A11

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN10338VTYYHKNVDPENVF-7.02209-7.13549
HLA-B14:023BVN10338VTYYHKNVDPENVF-5.91247-6.94777
HLA-B52:013W3910338VTYYHKNVDPENVF-6.32772-6.44112
HLA-B52:013W3910338VTYYHKNVDPENVF-5.9614-6.9967
HLA-A11:014UQ210338VTYYHKNVDPENVF-6.94253-7.05593
HLA-A24:025HGA10338VTYYHKNVDPENVF-6.37128-6.48468
HLA-A24:025HGA10338VTYYHKNVDPENVF-4.7171-5.7524
HLA-B27:056PYJ10338VTYYHKNVDPENVF-9.32138-9.43478
HLA-B44:053DX810338VTYYHKNVDPENVF-5.76938-5.88278
HLA-B44:053DX810338VTYYHKNVDPENVF-3.39597-4.43127
HLA-B35:011A1N10338VTYYHKNVDPENVF-5.49673-5.61013
HLA-B35:011A1N10338VTYYHKNVDPENVF-4.18915-5.22445
HLA-A02:016TDR10338VTYYHKNVDPENVF-6.95864-7.07204

Top

Vaccine Design for the FusionNeoAntigens of KCNH7-SLC38A11

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
KCNH7-SLC38A11chr2163693046chr21657960661020HKNVDPENVFACAAAAATGTTGATCCTGAAAACGTGTTTA
KCNH7-SLC38A11chr2163693046chr21657960661120KNVDPENVFAAAATGTTGATCCTGAAAACGTGTTTA
KCNH7-SLC38A11chr2163693046chr21657960661121KNVDPENVFIAAAATGTTGATCCTGAAAACGTGTTTATTG
KCNH7-SLC38A11chr2163693046chr21657960661220NVDPENVFATGTTGATCCTGAAAACGTGTTTA
KCNH7-SLC38A11chr2163693046chr21657960661221NVDPENVFIATGTTGATCCTGAAAACGTGTTTATTG
KCNH7-SLC38A11chr2163693046chr2165796066514EVTYYHKNVAGGTCACCTACTATCACAAAAATGTTG
KCNH7-SLC38A11chr2163693046chr2165796066920YHKNVDPENVFATCACAAAAATGTTGATCCTGAAAACGTGTTTA

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
KCNH7-SLC38A11chr2163693046chr2165796066116ERKVEVTYYHKNVDPAGAGGAAAGTGGAGGTCACCTACTATCACAAAAATGTTGATCCTG
KCNH7-SLC38A11chr2163693046chr2165796066217RKVEVTYYHKNVDPEGGAAAGTGGAGGTCACCTACTATCACAAAAATGTTGATCCTGAAA
KCNH7-SLC38A11chr2163693046chr2165796066318KVEVTYYHKNVDPENAAGTGGAGGTCACCTACTATCACAAAAATGTTGATCCTGAAAACG
KCNH7-SLC38A11chr2163693046chr2165796066419VEVTYYHKNVDPENVTGGAGGTCACCTACTATCACAAAAATGTTGATCCTGAAAACGTGT
KCNH7-SLC38A11chr2163693046chr2165796066520EVTYYHKNVDPENVFAGGTCACCTACTATCACAAAAATGTTGATCCTGAAAACGTGTTTA
KCNH7-SLC38A11chr2163693046chr2165796066621VTYYHKNVDPENVFITCACCTACTATCACAAAAATGTTGATCCTGAAAACGTGTTTATTG

Top

Information of the samples that have these potential fusion neoantigens of KCNH7-SLC38A11

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
BRCAKCNH7-SLC38A11chr2163693046ENST00000328032chr2165796066ENST00000303735TCGA-C8-A26Y

Top

Potential target of CAR-T therapy development for KCNH7-SLC38A11

check button Predicted 3D structure. We used RoseTTAFold.
239_KCNH7-SLC38A11_af6f2_pred.pdb


check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
TgeneSLC38A11chr2:163693046chr2:165796066ENST00000303735210121_1410385.0TransmembraneHelical
TgeneSLC38A11chr2:163693046chr2:165796066ENST00000303735210156_1760385.0TransmembraneHelical
TgeneSLC38A11chr2:163693046chr2:165796066ENST00000303735210202_2220385.0TransmembraneHelical
TgeneSLC38A11chr2:163693046chr2:165796066ENST00000303735210241_2630385.0TransmembraneHelical
TgeneSLC38A11chr2:163693046chr2:165796066ENST00000303735210279_2990385.0TransmembraneHelical
TgeneSLC38A11chr2:163693046chr2:165796066ENST00000303735210301_3210385.0TransmembraneHelical
TgeneSLC38A11chr2:163693046chr2:165796066ENST00000303735210340_3600385.0TransmembraneHelical
TgeneSLC38A11chr2:163693046chr2:165796066ENST0000030373521093_1130385.0TransmembraneHelical
TgeneSLC38A11chr2:163693046chr2:165796066ENST00000409149311121_1410407.0TransmembraneHelical
TgeneSLC38A11chr2:163693046chr2:165796066ENST00000409149311156_1760407.0TransmembraneHelical
TgeneSLC38A11chr2:163693046chr2:165796066ENST00000409149311202_2220407.0TransmembraneHelical
TgeneSLC38A11chr2:163693046chr2:165796066ENST00000409149311241_2630407.0TransmembraneHelical
TgeneSLC38A11chr2:163693046chr2:165796066ENST00000409149311279_2990407.0TransmembraneHelical
TgeneSLC38A11chr2:163693046chr2:165796066ENST00000409149311301_3210407.0TransmembraneHelical
TgeneSLC38A11chr2:163693046chr2:165796066ENST00000409149311340_3600407.0TransmembraneHelical
TgeneSLC38A11chr2:163693046chr2:165796066ENST0000040914931193_1130407.0TransmembraneHelical
TgeneSLC38A11chr2:163693046chr2:165796066ENST00000409662513121_1410407.0TransmembraneHelical
TgeneSLC38A11chr2:163693046chr2:165796066ENST00000409662513156_1760407.0TransmembraneHelical
TgeneSLC38A11chr2:163693046chr2:165796066ENST00000409662513202_2220407.0TransmembraneHelical
TgeneSLC38A11chr2:163693046chr2:165796066ENST00000409662513241_2630407.0TransmembraneHelical
TgeneSLC38A11chr2:163693046chr2:165796066ENST00000409662513279_2990407.0TransmembraneHelical
TgeneSLC38A11chr2:163693046chr2:165796066ENST00000409662513301_3210407.0TransmembraneHelical
TgeneSLC38A11chr2:163693046chr2:165796066ENST00000409662513340_3600407.0TransmembraneHelical
TgeneSLC38A11chr2:163693046chr2:165796066ENST0000040966251393_1130407.0TransmembraneHelical
TgeneSLC38A11chr2:163693047chr2:165796066ENST00000303735210121_1410385.0TransmembraneHelical
TgeneSLC38A11chr2:163693047chr2:165796066ENST00000303735210156_1760385.0TransmembraneHelical
TgeneSLC38A11chr2:163693047chr2:165796066ENST00000303735210202_2220385.0TransmembraneHelical
TgeneSLC38A11chr2:163693047chr2:165796066ENST00000303735210241_2630385.0TransmembraneHelical
TgeneSLC38A11chr2:163693047chr2:165796066ENST00000303735210279_2990385.0TransmembraneHelical
TgeneSLC38A11chr2:163693047chr2:165796066ENST00000303735210301_3210385.0TransmembraneHelical
TgeneSLC38A11chr2:163693047chr2:165796066ENST00000303735210340_3600385.0TransmembraneHelical
TgeneSLC38A11chr2:163693047chr2:165796066ENST0000030373521093_1130385.0TransmembraneHelical
TgeneSLC38A11chr2:163693047chr2:165796066ENST00000409149311121_1410407.0TransmembraneHelical
TgeneSLC38A11chr2:163693047chr2:165796066ENST00000409149311156_1760407.0TransmembraneHelical
TgeneSLC38A11chr2:163693047chr2:165796066ENST00000409149311202_2220407.0TransmembraneHelical
TgeneSLC38A11chr2:163693047chr2:165796066ENST00000409149311241_2630407.0TransmembraneHelical
TgeneSLC38A11chr2:163693047chr2:165796066ENST00000409149311279_2990407.0TransmembraneHelical
TgeneSLC38A11chr2:163693047chr2:165796066ENST00000409149311301_3210407.0TransmembraneHelical
TgeneSLC38A11chr2:163693047chr2:165796066ENST00000409149311340_3600407.0TransmembraneHelical
TgeneSLC38A11chr2:163693047chr2:165796066ENST0000040914931193_1130407.0TransmembraneHelical
TgeneSLC38A11chr2:163693047chr2:165796066ENST00000409662513121_1410407.0TransmembraneHelical
TgeneSLC38A11chr2:163693047chr2:165796066ENST00000409662513156_1760407.0TransmembraneHelical
TgeneSLC38A11chr2:163693047chr2:165796066ENST00000409662513202_2220407.0TransmembraneHelical
TgeneSLC38A11chr2:163693047chr2:165796066ENST00000409662513241_2630407.0TransmembraneHelical
TgeneSLC38A11chr2:163693047chr2:165796066ENST00000409662513279_2990407.0TransmembraneHelical
TgeneSLC38A11chr2:163693047chr2:165796066ENST00000409662513301_3210407.0TransmembraneHelical
TgeneSLC38A11chr2:163693047chr2:165796066ENST00000409662513340_3600407.0TransmembraneHelical
TgeneSLC38A11chr2:163693047chr2:165796066ENST0000040966251393_1130407.0TransmembraneHelical

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result
KCNH7chr2163693046ENST00000328032SLC38A11chr2165796066ENST00000303735

Top

Related Drugs to KCNH7-SLC38A11

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to KCNH7-SLC38A11

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource